Only two cases of hemolytic disease of the newborn caused by anti-Jk^a have been published. The first case, reported in 1951 by Allen, Diamond and Niedziela [1], was thought first to have been due primarily to the anti-Kell that was present also in Mrs. Kidd’s serum. Later, baby Kidd was grouped Kell negative so that now the anti-Jka is considered to have been the cause of its hemolytic disease. The second case was reported in 1956 by Greenwalt, Sasaki and Sneath [3]. In neither of these cases did the baby require exchange transfusion. Other examples of anti-Jk^a have been reported [2, 4-15], wich have been stimulated either by transfusion, pregnancy or by transfusion plus pregnancy. In most cases the anti-Jk^a has been accompanied by other blood group immune antibodies. In a case reported by Hunter, Lewis and Chown [6], anti-Jka appeared in the serum of a woman during her first pregnancy, but the baby was normal at birth. The mother had never been transfused. In the case which we describe the baby developed kernicterus and was given an exchange transfusion.

This content is only available via PDF.
1959
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.